Dimensioni, segmenti e analisi del mercato dei trattamenti per il disturbo da desiderio sessuale ipoattivo femminile entro il 2025-2031
Female Hypoactive Sexual Desire Disorder Therapeutics Market Report Analysis
Female Hypoactive Sexual Desire Disorder Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Allergan plc
- AMAG Pharmaceuticals, Inc.
- Emotional Brain BV
- Endoceutics, Inc.
- GlaxoSmithKline Plc
- Merck & Co., Inc.
- Palatin Technologies Inc
- Pivot Pharmaceuticals Inc
- Sprout Pharmaceuticals, Inc.
Regional Overview
- Nord America
- Europa
- Asia-Pacifico
- America centrale e meridionale
- Medio Oriente e Africa
Market Segmentation
By Terapia
- testosterone
- flibanserina
- buspirone
- bupropione
- bremelanotide
- terapia cognitivo comportamentale
By Applicazione
- ricovero
- ambulatoriale
By Geografia
- America del Nord
- Europa
- Asia-Pacifico
- America centrale e meridionale
Get Free Sample For